PURPOSE: Linkage of cancer registry data with complementary data sources can be an informative way to expand what is known about patients and their treatment and improve delivery of care. The purpose of this study was to explore whether patient smoking status and smoking-cessation modalities data in the Kentucky Cancer Registry (KCR) could be augmented by linkage with health claims data. METHODS: The KCR conducted a data linkage with health claims data from Medicare, Medicaid, state employee insurance, Humana, and Anthem. Smoking status was defined as documentation of personal history of tobacco use (International Classification of Diseases, Ninth Revision [ICD-9] code V15.82) or tobacco use disorder (ICD-9 305.1) before and after a cancer diagnosis. Use of smoking-cessation treatments before and after the cancer diagnosis was defined as documentation of smoking-cessation counseling (Healthcare Common Procedure Coding System codes 99406, 99407, G0375, and G0376) or pharmacotherapy (eg, nicotine replacement therapy, bupropion, varenicline). RESULTS: From 2007 to 2011, among 23,703 patients in the KCR, we discerned a valid prediagnosis smoking status for 78%. KCR data only (72%), claims data only (6%), and a combination of both data sources (22%) were used to determine valid smoking status. Approximately 4% of patients with cancer identified as smokers (n = 11,968) and were provided smoking-cessation counseling, and 3% were prescribed pharmacotherapy for smoking cessation. CONCLUSION: Augmenting KCR data with medical claims data increased capture of smoking status and use of smoking-cessation modalities. Cancer registries interested in exploring smoking status to influence treatment and research activities could consider a similar approach, particularly if their registry does not capture smoking status for a majority of patients.
PURPOSE: Linkage of cancer registry data with complementary data sources can be an informative way to expand what is known about patients and their treatment and improve delivery of care. The purpose of this study was to explore whether patient smoking status and smoking-cessation modalities data in the Kentucky Cancer Registry (KCR) could be augmented by linkage with health claims data. METHODS: The KCR conducted a data linkage with health claims data from Medicare, Medicaid, state employee insurance, Humana, and Anthem. Smoking status was defined as documentation of personal history of tobacco use (International Classification of Diseases, Ninth Revision [ICD-9] code V15.82) or tobacco use disorder (ICD-9 305.1) before and after a cancer diagnosis. Use of smoking-cessation treatments before and after the cancer diagnosis was defined as documentation of smoking-cessation counseling (Healthcare Common Procedure Coding System codes 99406, 99407, G0375, and G0376) or pharmacotherapy (eg, nicotine replacement therapy, bupropion, varenicline). RESULTS: From 2007 to 2011, among 23,703 patients in the KCR, we discerned a valid prediagnosis smoking status for 78%. KCR data only (72%), claims data only (6%), and a combination of both data sources (22%) were used to determine valid smoking status. Approximately 4% of patients with cancer identified as smokers (n = 11,968) and were provided smoking-cessation counseling, and 3% were prescribed pharmacotherapy for smoking cessation. CONCLUSION: Augmenting KCR data with medical claims data increased capture of smoking status and use of smoking-cessation modalities. Cancer registries interested in exploring smoking status to influence treatment and research activities could consider a similar approach, particularly if their registry does not capture smoking status for a majority of patients.
Authors: J Michael Underwood; Julie S Townsend; Eric Tai; Arica White; Shane P Davis; Temeika L Fairley Journal: J Cancer Surviv Date: 2012-06-16 Impact factor: 4.442
Authors: M Shayne Gallaway; Rebecca Glover-Kudon; Behnoosh Momin; Mary Puckett; Natasha Buchanan Lunsford; Kathleen R Ragan; Elizabeth A Rohan; Stephen Babb Journal: J Cancer Surviv Date: 2019-01-05 Impact factor: 4.442
Authors: David P Mason; Sreekumar Subramanian; Edward R Nowicki; Joshua D Grab; Sudish C Murthy; Thomas W Rice; Eugene H Blackstone Journal: Ann Thorac Surg Date: 2009-08 Impact factor: 4.330
Authors: Patricia A Ganz; Gail A Greendale; Laura Petersen; Barbara Kahn; Julienne E Bower Journal: J Clin Oncol Date: 2003-11-15 Impact factor: 44.544
Authors: James L Klosky; Vida L Tyc; Danette M Garces-Webb; Joanna Buscemi; Robert C Klesges; Melissa M Hudson Journal: Cancer Date: 2007-12-01 Impact factor: 6.860
Authors: Ralph S Caraballo; Paul R Shafer; Deesha Patel; Kevin C Davis; Timothy A McAfee Journal: Prev Chronic Dis Date: 2017-04-13 Impact factor: 2.830
Authors: M Kawahara; S Ushijima; T Kamimori; N Kodama; M Ogawara; K Matsui; N Masuda; M Takada; T Sobue; K Furuse Journal: Br J Cancer Date: 1998-08 Impact factor: 7.640
Authors: Sundar S Shrestha; Xin Xu; Xu Wang; Stephen D Babb; Brian S Armour; Brian A King; Katrina F Trivers Journal: Public Health Rep Date: 2021-02-18 Impact factor: 2.792
Authors: Kara L Larson; Bin Huang; Quan Chen; Thomas Tucker; Marissa Schuh; Susanne M Arnold; Jill M Kolesar Journal: PLoS One Date: 2020-08-18 Impact factor: 3.240